Structured treatment interruption in HIV-infected patients failing on multidrug therapy: is there a future for this strategy?

被引：4
作者：
Antinori, A
Cingolani, A
Perno, CF
机构：
[1] IRCCS, Natl Inst Infect Dis, Clin Dept, I-00149 Rome, Italy
[2] Catholic Univ, Dept Infect Dis, Rome, Italy
来源：
AIDS | 2005年 / 19卷 / 15期
关键词：
D O I：
10.1097/01.aids.0000183513.29890.0b
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1691 / 1694
页数：4
相关论文
共 23 条
  • [1] Blackham J, 2005, AIDS, V19, P487
  • [2] Ciancio BC, 2003, ANTIVIR THER, V8, P611
  • [3] Clinical management of treatment-experienced, HIV-infected patients with the fusion inhibitor enfuvirtide: consensus recommendations
    Clotet, B
    Raffi, F
    Cooper, D
    Delfraissy, JF
    Lazzarin, A
    Moyle, G
    Rockstroh, J
    Soriano, V
    Schapiro, J
    [J]. AIDS, 2004, 18 (08) : 1137 - 1146
  • [4] Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.
    Deeks, SG
    Wrin, T
    Liegler, T
    Hoh, R
    Hayden, M
    Barbour, JD
    Hellmann, NS
    Petropoulos, CJ
    McCune, JM
    Hellerstein, MK
    Grant, RM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (07) : 472 - 480
  • [5] Treatment of anti retroviral-drug-resistant HIV-1 infection
    Deeks, SG
    [J]. LANCET, 2003, 362 (9400) : 2002 - 2011
  • [6] CD4+ T cell kinetics and activation in human immunodeficiency virus-infected patients who remain viremic despite long-term treatment with protease inhibitor-based therapy
    Deeks, SG
    Hoh, R
    Grant, RM
    Wrin, T
    Barbour, JD
    Narvaez, A
    Cesar, D
    Abe, K
    Hanley, MB
    Hellmann, NS
    Petropoulos, CJ
    McCune, JM
    Hellerstein, MK
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (03) : 315 - 323
  • [7] DeGruttola V, 2000, ANTIVIR THER, V5, P41
  • [8] Re-occurrence of HIV-1 drug mutations after treatment re-initiation following interruption in patients with multiple treatment failure
    Delaugerre, C
    Valantin, MA
    Mouroux, M
    Bonmarchand, M
    Carcelain, G
    Duvivier, C
    Tubiana, R
    Simon, A
    Bricaire, F
    Agut, H
    Autran, B
    Katlama, C
    Calvez, V
    [J]. AIDS, 2001, 15 (16) : 2189 - 2191
  • [9] Devereux HL, 1999, AIDS, V13, pF123, DOI 10.1097/00002030-199912240-00001
  • [10] No benefit of a structured treatment interruption based on genotypic resistance in heavily pretreated HIV-infected patients
    Ghosn, J
    Wirden, M
    Ktorza, N
    Peytavin, G
    Aït-Mohand, H
    Schneider, L
    Dominguez, S
    Bricaire, F
    Calvez, V
    Costagliola, D
    Katlama, C
    [J]. AIDS, 2005, 19 (15) : 1643 - 1647
123